PROS1 and blood coagulation disease: Identifying predisposing factors, such as the increased expression of CD147 and the reduction in plasmatic PROS1 levels, could be instrumental in proactively determining the risk of coagulopathies associated with SARS-CoV-2 infection and LCS.